Non-small cell lung cancer (NSCLC) is the most common cancer, accounting for approximately 85% of the total lung cancers in the United States. Almost 230K new cases were diagnosed in 2022 alone. Moreover, significant deaths were recorded at the end of the same year, accounting for almost 130K deaths. As per DelveInsight’s analysis, it’s estimated that in 2020, there were almost 38K incident cases of EGFR-non-small cell lung cancer mutation in the United States.
Non-small cell lung cancer is any type of epithelial lung cancer other than SCLC. It is further subcategorized into adenocarcinomas, squamous cell carcinomas, and large cell carcinomas. There are other...
